Competitive intelligence in the South African pharmaceutical industry
DOI:
https://doi.org/10.37380/jisib.v3i1.53Keywords:
Competitive intelligence, pharmaceutical industry, South Africa, strategic decision-makingAbstract
Currently the South African pharmaceutical industry is being affected by legislation, as the government is readjusting the whole healthcare system to make it cost-effective and equitable. The purpose of this article is to establish what the current situation is within the South African pharmaceutical’s industry’s competitive intelligence (CI) capacity. Questionnaires were administered electronically to senior managers in the pharmaceutical industry. The majority of the respondents were of the opinion that a culture of information sharing and an environment of collaboration on competitive issues exist in their companies. Respondents confirm that CI is used on a continuous basis in strategic decision-making and that company strategies are used to manage competitors. It is recommended that senior management of pharmaceutical companies capitalise and consolidate the CI function which is used on a continuous basis in strategic decision-making.
References
Badr, A., Madden, E. & Wright, S. 2006. The contribution of CI to the strategic decision making process: Empirical study of the European pharmaceutical industry. Journal of Competitive Intelligence and Management 3 (4): 15-34.
Baines, D.A. 2010. Problems facing the pharmaceutical industry and approaches to ensure long term viability. Master of Science in Organisational Dynamics Dissertation. Philadelphia: University of Pennsylvania.
Bodibe, K. 2012. Anitretroviral drug supply disaster averted. Natal Mercury Newspaper 7 June: 4.
Blanke, J. 2007. Assessing Africa's competitiveness in a global context. Available http://www.members.weforum.org/pdf./gcr/africa/1.1pdf : 1-26. [Accessed 17 April 2012].
Buck-Luce, C. 2011. Pharma 3.0 and the new healthcare eco-system. Keynote address delivered at Pharma CI Conference Parisppany Hotel, New Jersey. 13-14 September 2011. Available http://www.nature.com/nbt/journal/V18/n/05/full/hbt1000-IT5.html. [Accessed 5 May 2012].
Buthlezi, L. 2012. Pharma dynamics : Drug price cut to benefit more. Mercury Business Report 5 June:19.
Correia, C.C. 2003. Features how competitive is your law firm? CI for the legal industry. Available http://www.llrx.con/node/1043/print [Accessed 8 August 2012].
Du Toit, A.S.A. 2003. Competitive intelligence in the knowledge economy: What is in it for South African manufacturing enterprises? International Journal of Information Management 23(1):111-120. DOI: https://doi.org/10.1016/S0268-4012(02)00103-2
Du Toit, A.S.A. & Sewdass, N. 2012. Current state of competitive intelligence in South Africa. Proceedings of the International Conference on Knowledge Management, 4-6 September. Johannesburg: University of Johannesburg.
Du Toit, A.S.A. & Strauss, C. 2010. Competitive intelligence and Africa's competitiveness: what's happening in South Africa? Mousaion 28(2): 17-32.
Evans, M. 2005. Global CI – best practice methods. Conference proceedings of the Competitive Intelligence conference, held in Somerset West. Available http://www.marketing-intelligence.co.uk/datasources [Accessed 12 August 2012].
Hall, C. & Bensoussan, B. 2007. Staying ahead of the competition: How firms really manage their competitive intelligence and knowledge; evidence from a decade of rapid change. New York: World Scientific Publishing Data. DOI: https://doi.org/10.1142/9789812779076
Henderson, M. 2011. A bitter pill: Is big pharm prepared to swallow a new business model? The Times Eureka supplement 28 February: 35-39.
Kahn, T. 2012. Discovery warns industry on biologic drugs costs. Business Day 6 June: 10.
Martin, T. 2002. Pharmaceutical care in the armed forces, American Pharmaceutical Association Annual Meeting, Philadelphia.
McGonagle, J.J. & Vella, C.M. 2002. A case for competitive intelligence. Information Management Journal July/August: 35-50.
MIMS DESK REFERENCE.2011. Directory of Manufacturers: Johannesburg: MIMS.
Montague, C. & Oosthuizen, H. 2010. Growing the fruits of HIV/AIDS. Leadership Lab 4(1): 22:24.
O'Leary, Z. 2005. Researching real world problems : A guide to methods of inquiry. London: Sage Publications.
Richardson, D. 2008. Fully dedicated competitive intelligence groups on the rise. Cutting edge information study finds. Available http://findarticles.com/p/articles/ini-pwwwi/is-200807/ai-n27974662/ [Accessed 1 September 2012].
RNCOS Industry Research Solutions. 2011. SA pharmaceutical industry competitive landscape. Available http://www.rncos.com/report/imz48.htm [Accessed 16 April 2012].
Sewlal, R. 2004. Effectiveness of the Web as a competitive intelligence tool. South African Journal of Information Management 6(1): 1-16. Available .http://general.rau.ac.za/infoci/www:2003/papers/Sewlal%20R%20Effectiveness%20of20%..pdf [Accessed 20 November 2011]. DOI: https://doi.org/10.4102/sajim.v6i1.293
Timur, A . 2006. The single market and pharmaceutical industry in the European Union: Is there any evidence of price convergence? Available http://scholar-commons.usf.edu/cgi/viewcontent.cgi?article=3727......etd [Accessed 8 June 2012].
Viviers, W., Muller M.L. & Du Toit, A.S.A. 2005. Competitive intelligence: An instrument to enhance South Africa's competitiveness. South African Journal of Economic and Management Sciences 8(2): 246-254. DOI: https://doi.org/10.4102/sajems.v8i2.1232
Wright, S., Fleischer, C.S. & Madden. E. 2008. Characteristics of competitive intelligence practice in R&D driven firms: evidence from the U.K. pharmaceutical industry. Available .http://dora.dmu.ac.uk/bitstream/handle/2086/ [Accessed 24 May 2012].
Downloads
Published
Issue
Section
License
Copyright (c) 2013 Journal of Intelligence Studies in Business
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
